Beijing SL Pharmaceutical Co., Ltd. (SHE:002038)
6.91
+0.05 (0.73%)
May 30, 2025, 2:45 PM CST
Beijing SL Pharmaceutical Revenue
Beijing SL Pharmaceutical had revenue of 168.90M CNY in the quarter ending March 31, 2025, a decrease of -31.10%. This brings the company's revenue in the last twelve months to 584.20M, down -39.58% year-over-year. In the year 2024, Beijing SL Pharmaceutical had annual revenue of 660.42M, down -35.15%.
Revenue (ttm)
584.20M
Revenue Growth
-39.58%
P/S Ratio
12.15
Revenue / Employee
682.48K
Employees
856
Market Cap
7.10B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 660.42M | -357.94M | -35.15% |
Dec 31, 2023 | 1.02B | -31.81M | -3.03% |
Jan 1, 2023 | 1.05B | -164.65M | -13.55% |
Jan 1, 2022 | 1.21B | 102.08M | 9.17% |
Dec 31, 2020 | 1.11B | -916.97M | -45.18% |
Dec 31, 2019 | Pro | Pro | Pro |
Jan 1, 2019 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |